Development and use of iron oxide nanoparticles (Part 2): The application of iron oxide contrast agents in MRI
Open Access
- 1 April 2010
- journal article
- Published by Department of Biomedical Imaging, University of Malaya, Malaysia in Biomedical Imaging and Intervention Journal
- Vol. 6 (2)
- https://doi.org/10.2349/biij.6.2.e13
Abstract
Biomedical Imaging and Intervention Journal (biij) - A multidisciplinary open access online biomedical imaging and radiology journalKeywords
This publication has 93 references indexed in Scilit:
- Clinical and histological findings in nephrogenic systemic fibrosisEuropean Journal of Radiology, 2008
- Nephrogenic systemic fibrosis associated with gadolinium based contrast agents: A summary of the medical literature reportingEuropean Journal of Radiology, 2008
- Nanoparticles in Biomedical ImagingPublished by Springer Science and Business Media LLC ,2008
- Nephrogenic systemic fibrosis: A clinicopathologic study of six casesJournal of the American Academy of Dermatology, 2007
- Gadolinium is detectable within the tissue of patients with nephrogenic systemic fibrosisJournal of the American Academy of Dermatology, 2007
- Nanobiotechnology IIPublished by Wiley ,2007
- Is there a causal relation between the administration of gadolinium based contrast media and the development of nephrogenic systemic fibrosis (NSF)?Clinical Radiology, 2006
- Editorials: Nephrogenic Systemic Fibrosis: An Emerging Threat Among Renal PatientsSeminars in Dialysis, 2006
- Nephrogenic Systemic Fibrosis: The Nosological and Conceptual Evolution of Nephrogenic Fibrosing DermopathyAmerican Journal of Kidney Diseases, 2005
- Scleromyxoedema-like cutaneous diseases in renal-dialysis patientsThe Lancet, 2000